LAMO - Overview: Lamotrigine, Serum
Monitoring serum concentration of lamotrigine Assessing compliance Adjusting lamotrigine dose in patients receiving other anticonvulsant drugs that interact pharmacokinetically with lamotrigine
LD - Overview: Lactate Dehydrogenase (LDH), Serum
Investigation of a variety of diseases involving the heart, liver, muscle, kidney, lung, and blood Monitoring changes in tumor burden after chemotherapy; lactate dehydrogenase elevations in patients with cancer are too erratic to be of use...
OMHC - Overview: Oxcarbazepine Metabolite, Serum
Monitoring serum concentration during oxcarbazepine therapy Assessing compliance Assessing potential toxicity
MITF - Overview: MiTF Immunostain, Technical Component Only
Identification of melanomas
MGB - Overview: Mammaglobin (MGB) Immunostain, Technical Component Only
Breast-specific marker Aids in evaluating tumors of unknown primary site
MNCU - Overview: Manganese/Creatinine Ratio, Urine
Measurement of manganese as a part of a profile Monitoring manganese exposure Nutritional monitoring Clinical trials
SMOTH - Overview: Smoothelin Immunostain, Technical Component Only
Distinguishing muscularis mucosae from muscularis propria
POSA - Overview: Posaconazole, Serum
Monitoring posaconazole therapy
D240 - Overview: Podoplanin (D2-D40) Immunostain, Technical Component Only
Aids in the identification of reactive follicular dendritic cells
VORI - Overview: Voriconazole, Serum
Monitoring trough levels of voriconazole is suggested for: -Individuals with reduced liver function -Individuals with cytochrome P450 (CYP) 2C19 alterations associated with poor metabolic function -Patients taking other medications that...
Mayo Clinic Ranked No. 1 Hospital Nationwide by U.S. News & World Report - Insights
Report’s 29th annual "Best Hospitals Honor Roll" published online on August 14. Mayo Clinic also ranked No. 1 in more specialties than any other hospital in the country....
NELL-1 [Test in Focus] - Insights
D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic...
Looking Back on Clinical Chemistry 1 - Insights
in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course....
Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights
test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT to diagnose type 1 narcolepsy....
Week in Review: November 1 - Insights
Top highlights include: Facebook launches into the digital space of healthcare, medical breakthrough for Ebola, and how the brain makes memories.